Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | calpain-like cysteine peptidase, putative | 0.004 | 0.0641 | 1 |
Schistosoma mansoni | calpain-7 (C02 family) | 0.004 | 0.0641 | 0.0641 |
Echinococcus granulosus | family C2 unassigned peptidase C02 family | 0.0111 | 0.2762 | 0.2762 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.004 | 0.0641 | 1 |
Brugia malayi | calpain 5 | 0.0028 | 0.0281 | 0.1073 |
Brugia malayi | calpain 7 | 0.004 | 0.0641 | 0.2448 |
Echinococcus multilocularis | calpain | 0.004 | 0.0641 | 0.0641 |
Schistosoma mansoni | hypothetical protein | 0.0354 | 1 | 1 |
Brugia malayi | calpain family protein 1 | 0.0106 | 0.2619 | 1 |
Echinococcus granulosus | calpain A | 0.0111 | 0.2762 | 0.2762 |
Trypanosoma cruzi | cysteine peptidase, Clan CA, family C2, putative | 0.004 | 0.0641 | 1 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0019 | 0 | 0.5 |
Trypanosoma brucei | calpain-like protein, putative | 0.004 | 0.0641 | 1 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.004 | 0.0641 | 1 |
Trypanosoma cruzi | calpain cysteine peptidase, putative | 0.004 | 0.0641 | 1 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C2, putative | 0.004 | 0.0641 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0078 | 0.1781 | 0.6801 |
Entamoeba histolytica | calpain large subunit domain III containing protein | 0.0028 | 0.0281 | 1 |
Trypanosoma brucei | calpain-like protein, putative | 0.004 | 0.0641 | 1 |
Schistosoma mansoni | family C2 unassigned peptidase (C02 family) | 0.0106 | 0.2619 | 0.2619 |
Echinococcus multilocularis | calpain family protein 1, d | 0.0078 | 0.1781 | 0.1781 |
Trypanosoma brucei | antigen, putative | 0.004 | 0.0641 | 1 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0019 | 0 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0019 | 0 | 0.5 |
Echinococcus multilocularis | calpain 7 (C02 family) | 0.004 | 0.0641 | 0.0641 |
Schistosoma mansoni | family C2 unassigned peptidase (C02 family) | 0.0111 | 0.2762 | 0.2762 |
Leishmania major | calpain, putative,cysteine peptidase, Clan CA, family C2, putative | 0.004 | 0.0641 | 1 |
Trypanosoma cruzi | kinesin, putative | 0.0028 | 0.0281 | 0.4383 |
Trypanosoma brucei | calpain-like protein, putative | 0.004 | 0.0641 | 1 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0019 | 0 | 0.5 |
Trypanosoma brucei | calpain-like protein, putative | 0.004 | 0.0641 | 1 |
Loa Loa (eye worm) | calpain family protein 1 | 0.0078 | 0.1781 | 0.6801 |
Schistosoma mansoni | calpain-7 (C02 family) | 0.004 | 0.0641 | 0.0641 |
Trypanosoma cruzi | cysteine peptidase, Clan CA, family C2, putative | 0.004 | 0.0641 | 1 |
Schistosoma mansoni | family C2 unassigned peptidase (C02 family) | 0.0111 | 0.2762 | 0.2762 |
Leishmania major | calpain-like cysteine peptidase, putative,cysteine peptidase, Clan CA, family C2, putative | 0.004 | 0.0641 | 1 |
Entamoeba histolytica | protein kinase, putative | 0.0028 | 0.0281 | 1 |
Loa Loa (eye worm) | calpain | 0.004 | 0.0641 | 0.2448 |
Echinococcus multilocularis | geminin | 0.0354 | 1 | 1 |
Echinococcus granulosus | calpain 7 C02 family | 0.004 | 0.0641 | 0.0641 |
Loa Loa (eye worm) | hypothetical protein | 0.0106 | 0.2619 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0066 | 0.1421 | 0.5426 |
Loa Loa (eye worm) | hypothetical protein | 0.0094 | 0.2258 | 0.8625 |
Trypanosoma brucei | kinesin, putative | 0.0028 | 0.0281 | 0.4383 |
Echinococcus multilocularis | family C2 unassigned peptidase (C02 family) | 0.0111 | 0.2762 | 0.2762 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.004 | 0.0641 | 1 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0019 | 0 | 0.5 |
Echinococcus multilocularis | calpain 5 | 0.004 | 0.0641 | 0.0641 |
Echinococcus granulosus | calpain 5 | 0.004 | 0.0641 | 0.0641 |
Echinococcus granulosus | calpain | 0.004 | 0.0641 | 0.0641 |
Leishmania major | kinesin, putative | 0.0028 | 0.0281 | 0.4383 |
Onchocerca volvulus | 0.0066 | 0.1421 | 0.5 | |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0019 | 0 | 0.5 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.004 | 0.0641 | 1 |
Schistosoma mansoni | Mername-AA248 (C02 family) | 0.004 | 0.0641 | 0.0641 |
Toxoplasma gondii | exonuclease III APE | 0.0019 | 0 | 0.5 |
Loa Loa (eye worm) | calpain family protein 1 | 0.0106 | 0.2619 | 1 |
Trypanosoma cruzi | cysteine peptidase, Clan CA, family C2, putative | 0.004 | 0.0641 | 1 |
Trypanosoma cruzi | cysteine peptidase, Clan CA, family C2, putative | 0.004 | 0.0641 | 1 |
Echinococcus granulosus | calpain A | 0.004 | 0.0641 | 0.0641 |
Schistosoma mansoni | hypothetical protein | 0.0354 | 1 | 1 |
Loa Loa (eye worm) | calpain 5 | 0.0028 | 0.0281 | 0.1073 |
Echinococcus multilocularis | calpain A | 0.0111 | 0.2762 | 0.2762 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.004 | 0.0641 | 1 |
Schistosoma mansoni | calpain C (C02 family) | 0.004 | 0.0641 | 0.0641 |
Schistosoma mansoni | calpain (C02 family) | 0.004 | 0.0641 | 0.0641 |
Trypanosoma cruzi | kinesin, putative | 0.0028 | 0.0281 | 0.4383 |
Plasmodium vivax | calpain, putative | 0.004 | 0.0641 | 1 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0019 | 0 | 0.5 |
Leishmania major | calpain-like cysteine peptidase, putative,cysteine peptidase, Clan CA, family C2, putative | 0.004 | 0.0641 | 1 |
Echinococcus multilocularis | hypothetical protein | 0.004 | 0.0641 | 0.0641 |
Brugia malayi | calpain family protein 1 | 0.0106 | 0.2619 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.